These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. [Immunogenetic studies of familial occurrence of progressive systemic scleroderma and circumscribed scleroderma]. Holzmann H; Schlieter A; Altmeyer P; Kühnl P Hautarzt; 1992 Sep; 43(9):548-53. PubMed ID: 1399599 [TBL] [Abstract][Full Text] [Related]
31. Antibodies eluted from lymphoid cell membrane. Occurrence in certain varieties of scleroderma. Cormane RH; Hamerlinck F; Nunzi E Arch Dermatol; 1979 Jun; 115(6):709-12. PubMed ID: 453872 [TBL] [Abstract][Full Text] [Related]
32. Antinucleosome antibody is a major autoantibody in localized scleroderma. Sato S; Kodera M; Hasegawa M; Fujimoto M; Takehara K Br J Dermatol; 2004 Dec; 151(6):1182-8. PubMed ID: 15606513 [TBL] [Abstract][Full Text] [Related]
33. Immunochemical characterization of the anti-RNA antibodies found in scleroderma and systemic lupus erythematosus. II. Reactivity with hsa-coupled, uridine-containing, monophosphoric ribodinucleotides. Alarcón-Segovia D; Fishbein E; Estrada-Parra S; García-Ortigoza E Immunology; 1976 Mar; 30(3):413-8. PubMed ID: 1082854 [TBL] [Abstract][Full Text] [Related]
34. [The value of humoral immune phenomena in children and adolescents with circumscribed scleroderma]. Albrecht-Nebe H; Stojanow K; Ziegler H; Eggert W; Barthelmes H Kinderarztl Prax; 1989 Jul; 57(7):315-26. PubMed ID: 2796119 [TBL] [Abstract][Full Text] [Related]
35. Anti-U3 snRNP antibodies in localised scleroderma. Yimane K; Ihn H; Kubo M; Asano Y; Yazawa N; Tamaki K Ann Rheum Dis; 2001 Dec; 60(12):1157-8. PubMed ID: 11760725 [No Abstract] [Full Text] [Related]
36. [Indications of the systemic character of circumscript scleroderma in children and adolescents]. Albrecht-Nebe H; Eggert W; Ziegler H; Barthelmes H; Wolf S Dermatol Monatsschr; 1987; 173(3):123-30. PubMed ID: 3496247 [No Abstract] [Full Text] [Related]
38. [Serum antinuclear antibodies (in patients with visceral erythematodes, rheumatoid arthritis, progressive systemic sclerosis and discoid erythematodes)]. Horvat Z Acta Med Iugosl; 1970; 24(3):229-40. PubMed ID: 4928076 [No Abstract] [Full Text] [Related]
39. Chromosome studies in scleroderma with consideration of anticentromere antibody status and assessment of possible in vitro clastogenic activity. Powell FC; Schroeter AL; Winkelmann RK; Dewald GW Acta Derm Venereol; 1986; 66(5):414-8. PubMed ID: 2431579 [TBL] [Abstract][Full Text] [Related]
40. Clinical relevance of immunologic findings in scleroderma. Jablonska S; Blaszczyk M; Chorzelski TP; Jarzabek-Chorzelska M; Kumar V; Beutner EH Clin Dermatol; 1992; 10(4):407-21. PubMed ID: 1303806 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]